alexa Ecopharmacovigilance And Its Impact On Clinical Practice
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Khushbu B Vaghasiya
Posters: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.014
Abstract
With growing years of technological advances, newer and more effective drugs are being manufactured and are used on an ever growing scale for people with medical conditions. Pharmacovigilance activities are done for monitoring, detection, assessment, understanding and prevention of any obnoxious adverse reactions to drug at therapeutic concentration on animal and human beings. With growing research in the field of ecology and environment, many of the adverse effects of these on the environment have come to light. And it has given a birth to the science of Ecopharmacovigilance. It has been an area of novel interest. It is too broad and not even defined in a clear manner. It aims to ensure that significant environmental issues associated with pharmaceuticals in the environment are identified in a timely way, and managed appropriately. The greatest challenge in EPV is of signal detection in environment and establishment of cause and effect. EPV has become a research topic in Europe and North America. A number of findings related to rising level of some drugs and their adverse effects on the flora and fauna has necessitated some action by regulatory agencies like FDA and European Union. And Environmental Risk Assessment (ERA) is a regulatory requirement prior to new drug launch. But still there is no proper protocol for monitoring potential adverse effects on environment after the product is launched. There should be laws and regulations on EPV, rational medication, drug take back programmes, policy guided and scientific researches on EPV by pharmaceutical firms and academia. In this review article, focus is on what EPV means in clinical practice and there what practical measures can be taken to assess environmental risks across product life cycle, particularly after launch of new drug, to ensure that our risk assessment and understanding of pharmaceuticals in the environment remain scientifically and ecologically relevant. These include: tracking environmental risks after launch of product, define cause and effect via literature monitoring, using Environmental Risk Management Plans (ERMPs) as a centralized resource for the assessment and management of the risk of drug throughout its life cycle. Keeping the global EPV as a prospective measure, in India we need to increase transparency and availability of environmental data for medicinal products.
Biography
Khushbu B Vaghasiya is pursuing residency in Pharmacology (3rd year), GMC, Surat affiliating VNSGU. She has published one article in international journal. Presently she is working on project ?Estimation of thyroid profile in patients of Diabetes mellitus?.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords